학술논문

Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
Document Type
Article
Source
American Journal of Health-System Pharmacy. 1/15/2023, Vol. 80 Issue 2, p53-60. 8p. 2 Charts.
Subject
*THERAPEUTICS
*DRUG efficacy
*HEALTH services administrators
*PAIN
*GENERIC drug substitution
*FOCUS groups
*HEALTH services accessibility
*EVALUATION of human services programs
*ATTITUDES of medical personnel
*ATTITUDE (Psychology)
*RESEARCH methodology
*SOCIAL workers
*HEALTH facility administration
*AGE distribution
*STAKEHOLDER analysis
*DEPRESCRIBING
*INTERVIEWING
*HUMAN services programs
*QUALITATIVE research
*PHARMACISTS
*SELF-efficacy
*DESCRIPTIVE statistics
*PSYCHOSOCIAL factors
*HOSPITAL nursing staff
*INTERPROFESSIONAL relations
*THEMATIC analysis
*INTEGRATED health care delivery
*PAIN management
*PSYCHOLOGY of physicians
*EVALUATION
*OLD age
Language
ISSN
1079-2082
Abstract
Purpose Opportunities exist to meaningfully reduce suboptimal prescription opioid use among older adults. Deprescribing is one possible approach to reducing suboptimal use. Appropriate interventions should outline how to carefully taper opioids, closely monitor adverse events, substitute viable alternative and affordable nonopioid pain treatments, and initiate medications for opioid use disorder to properly manage use disorders, as needed. We sought to document and understand provider perceptions to begin developing effective and safe opioid deprescribing interventions. Methods We conducted 3 semistructured focus groups that covered topics such as participant perspectives on opioid deprescribing in older adults, how to design an ideal intervention, and how to identify potential barriers or facilitators in implementing an intervention. Focus group transcripts were double coded and qualitatively analyzed to identify overarching themes. Results Healthcare providers (n = 17), including physicians, pharmacists, nurses, social workers, and administrative staff, participated in 3 focus groups. We identified 4 key themes: (1) involve pharmacists in deprescribing and empower them as leaders of an opioid deprescribing service; (2) ensure tight integration and close collaboration throughout the deprescribing process from the inpatient to outpatient settings; (3) more expansive inclusion criteria than age alone; and (4) provision of access to alternative pharmacological and nonpharmacological pain management modalities to patients. Conclusion Our findings, which highlight various healthcare provider beliefs about opioid deprescribing interventions, are expected to serve as a framework for other organizations to develop and implement interventions. Future studies should incorporate patients' and family caregivers' perspectives. [ABSTRACT FROM AUTHOR]